Atlas Trials

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Clinical trial NCT00501293 · COMPLETED

Trial details

NCT number
NCT00501293
Sponsor
Noven Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
ADHD
Start date
2007-08-01
Primary completion
2009-02-01
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.